browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
45bf26aa-e4a5-4bf7-9619-bb7a6669f75d
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 13:53:12
Income (reported)
$10,000
Expenses (reported)
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

BELL & LINDSAY, INC.

Lobbying and Consulting

Contact
MARK LINDSAY
Phone
+1 202-905-7345
Address
zip:20024, city:Washington, state:DC, street:425 3rd St SW # 1250
Client

OYE THEREPEUTICS

Pharmaceutical, development stage, company

State
IN
Country
US
Government-entity client
false
Effective date
2021-03-22
Issues lobbied + lobbyists (1)

HCR — Health Issues

General Consulting and informing federal agencies and Congress on the research that OYE Therapeutics is currently doing.

Lobbyists:

Government entities lobbied: Defense, Dept of (DOD); Executive Office of the President (EOP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Office of Natl Drug Control Policy (NDCP); Office of Science & Technology Policy (OSTP); SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.